Skip to Main Content

Paper Details

Validation and structural characterization of the LEDGF/p75-MLL interface as a new target for the treatment of MLL-dependent leukemia.
Cancer Res
38
2014
Author NameAffiliation
Jonas DemeulemeesterDepartment of Pharmaceutical and Pharmacological Sciences
  • 1 - 1

Datasets

Release 1.2